U.S. Hematology Update eNewsletter
February 2020

Advances in Waldenström’s Macroglobulinemia
Waldenström’s macroglobulinemia (WM) is a rare, malignant, hematological monoclonal gammopathy that shares several traits with multiple myeloma (MM). While the presence of elevated IgM levels is similar between the two blood disorders, WM is often also associated with lymphadenopathy, hepatosplenomegaly, and increased blood viscosity, which are absent in MM. Until recently, little was known about WM. However, new advances have identified clinical and genetic markers. Read more.


Avoiding Infections in
Hematological Disorders 

While immunosuppressives can be lifesaving in patients with immune-mediated hematological disorders, this benefit comes with a price, which includes the development of bacterial and viral infections, and reactivation of tuberculosis, toxoplasmosis, varicella zoster, or viral hepatitis. A recent review offered strategies to help prevent infectious complications in patients undergoing treatment. Read more.

Diagnosing and Managing
Early and Advanced-Stage Follicular Lymphoma

Follicular lymphoma (FL), the second most common type of lymphoma in the United States, accounts for about 35% of all non-Hodgkin lymphoma cases. A recent update on the diagnosis and management of FL discusses the diagnosis, prognosis, and treatment options for early and advanced-stage disease and relapsed FL. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App